I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Effect of a genetically engineered interferon-alpha versus ..:
Chuan Li
;
Fengming Luo
;
Chengwu Liu
...
https://www.tandfonline.com/doi/10.1080/07853890.2021.1890329. , 2021
Link:
https://doi.org/10.1080/07853890.2021.1890329
RT Journal T1
Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:1c8e5e4bc8854d9e90ac0409a97370b6&Exemplar=1&LAN=DE A1 Chuan Li A1 Fengming Luo A1 Chengwu Liu A1 Nian Xiong A1 Zhihua Xu A1 Wei Zhang A1 Ming Yang A1 Ye Wang A1 Dan Liu A1 Chao Yu A1 Jia Zeng A1 Li Zhang A1 Duo Li A1 Yanbin Liu A1 Mei Feng A1 Ruoyang Liu A1 Jiandong Mei A1 Senyi Deng A1 Zhen Zeng A1 Yuanhong He A1 Haiyan Liu A1 Zhengyu Shi A1 Meng Duan A1 Deying Kang A1 Jiayu Liao A1 Weimin Li A1 Lunxu Liu PB Taylor & Francis Group YR 2021 K1 COVID-19 K1 SARS-CoV-2 K1 interferon-alpha K1 recombinant super-compound interferon K1 treatment K1 Medicine K1 R JF https://www.tandfonline.com/doi/10.1080/07853890.2021.1890329 LK http://dx.doi.org/https://doi.org/10.1080/07853890.2021.1890329 DO https://doi.org/10.1080/07853890.2021.1890329 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)